MediPharm Labs
151 John Street,
Barrie, L4N 2L1, ON,
Canada
Barrie, L4N 2L1, ON,
Canada
1 705-719-7425
Life Sciences
MediPharm Labs Technographics
MediPharm Labs Software Purchases and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by MediPharm Labs and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 190 MediPharm Labs employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that MediPharm Labs has purchased the following applications: TruTrace StrainSecure for Blockchain Platform in 2020, Cisco Webex Meetings for Audio Video and Web Conferencing in 2019, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems MediPharm Labs is running and its propensity to invest more and deepen its relationship with TruTrace , Cisco Systems , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing MediPharm Labs revenues, which have grown to $17.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for MediPharm Labs intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
MediPharm Labs Data, Technology Stack, and Enterprise Applications
Blockchain
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| TruTrace | Legacy | TruTrace StrainSecure | Blockchain Platform | Blockchain | n/a | 2020 | 2020 |
In 2020, MediPharm Labs deployed TruTrace StrainSecure, using the Blockchain Platform to provide blockchain-secured seed-to-sale tracking for multiple MediPharm-manufactured products that were enrolled in a University Health Network and Medical Cannabis by Shoppers observational clinical study in Canada. The deployment of TruTrace StrainSecure was explicitly scoped to support real-world evidence capture for an investigator-led study, tying product provenance directly to clinical research workflows.
The implementation leveraged category-aligned capabilities including an immutable provenance ledger, timestamped chain-of-custody event logging, and product identity and batch-level traceability to record cultivation, processing, and distribution events. Configuration focused on capturing supply chain events relevant to clinical study protocols so that each product lot used in the study could be unambiguously referenced in research data and audit records.
Operationally the TruTrace StrainSecure implementation covered manufacturing and supply chain functions within MediPharm Labs and extended access to study administrators and clinical investigators in Canada, enabling controlled read and write permissions for participants in the observational study. Functional handoffs were centered on material handling, lot release documentation, and research evidence collection, aligning manufacturing records with study-specific provenance requirements.
Governance changes included enforcing blockchain-backed audit trails and role-based access controls to preserve data integrity for the study, and process adjustments to ensure study material events were recorded at points of cultivation, processing, and distribution. The deployment produced clearer product provenance for the clinical trial and improved research fidelity in the real-world evidence study, as reported by the study sponsors.
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Cisco Systems | Legacy | Cisco Webex Meetings | Audio Video and Web Conferencing | Collaboration | n/a | 2019 | 2019 |
In 2019, MediPharm Labs implemented Cisco Webex Meetings for Audio Video and Web Conferencing. The deployment is surfaced on the company website and provides browser based and client based meeting access for both internal collaboration and external participant engagement. Cisco Webex Meetings is configured to support scheduled meetings, ad hoc sessions, screen sharing, recording controls, and host participant management, reflecting typical Audio Video and Web Conferencing functional workflows.
The implementation integrates meeting join flows into public web pages so external users can access sessions via web links, while administrative controls and meeting configuration are managed within the Cisco Webex platform. Governance uses role based meeting administration and standard access controls to align meeting operations with corporate communication workflows, impacting corporate communication and external engagement functions.
|
|
|
|
|
Collaboration | Collaboration |
|
2018 | 2018 |
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2019 | 2019 |
In 2019, MediPharm Labs implemented Exclaimer Cloud Signatures for Office 365. MediPharm Labs deployed Exclaimer Cloud Signatures for Office 365 as a Digital Signing solution to centralize email signature management across the company and align corporate email with brand and regulatory text requirements.
The implementation uses centralized template management and server side signature application to apply consistent HTML signatures and contact blocks. Configuration included rule based signature assignment and template personalization driven by user attributes available within Office 365, ensuring signatures are applied without endpoint installs.
Integration is centered on Office 365 mail flow, with the Exclaimer Cloud Signatures for Office 365 footprint visible in the corporate website source, indicating public referencing of signature templates or associated vendor resources. Operational coverage is company wide across corporate communications, marketing and sales email channels, reflecting a single point of signature policy enforcement for external and internal messages.
Governance was structured to centralize signature template ownership, approval workflows, and policy controls for regulated communications common in the life sciences sector. The deployment framed signature management as an IT and communications function, standardizing processes for template updates, legal disclaimers and branding across MediPharm Labs.
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2022 | 2022 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs), Archive as a Service (AaaS) | CyberSecurity |
|
2019 | 2019 |
|
IT Decision Makers and Key Stakeholders at MediPharm Labs
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by MediPharm Labs Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD MediPharm Labs Technographics
MediPharm Labs is a Life Sciences organization based in Canada,
with around 190 employees and annual revenues of $17.0 million.
MediPharm Labs operates a diverse technology stack with applications such as
TruTrace StrainSecure, Cisco Webex Meetings and Exclaimer Cloud Signatures for Office 365,
covering areas like Blockchain Platform, Audio Video and Web Conferencing and Digital Signing.
MediPharm Labs has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as TruTrace, Cisco Systems and Exclaimer.
MediPharm Labs recently adopted applications including
Amazon EC2 in 2022, Fastly in 2022 and Cloudflare CDN in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of MediPharm Labs’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates MediPharm Labs’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete MediPharm Labs technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.